PROCEPT BioRobotics Corporation (PRCT) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

18/25

Growth 4 Margin 5 Expansion 5 Platform 2 Financial 2

latest quarter score

Earnings Reports

18
Procept BioRobotics (PRCT) Q2 2026: Hydros Upgrades Drive 32% System Revenue Growth Amid Legacy Headwinds
August 05, 2026
16
Procept Biorobotics (PRCT) Q1 2026: U.S. System ASP Hits $485K, Pricing Discipline Drives Margin Recovery
April 30, 2026
14
Procept Biorobotics (PRCT) Q4 2025: Handpiece ASP Jumps 9% as Pricing Discipline Resets Growth Trajectory
February 26, 2026
13
Procept Biorobotics (PRCT) Q4 2025: Handpiece Price Up 5% as Bulk Discount Era Ends
February 26, 2026
16
Procept Biorobotics (PRCT) Q3 2025: U.S. Handpiece Volume Jumps 51% as Utilization Initiatives Intensify
November 05, 2025
21
ProCEPT BioRobotics (PRCT) Q2 2025: 640bps Margin Expansion Signals Durable Operating Leverage
August 06, 2025
23
Procept Biorobotics (PRCT) Q1 2025: Hydros Drives 55% Revenue Growth as IDN Adoption Accelerates
July 07, 2025
PROCEPT BioRobotics (PRCT) Q4 2024: 57% Revenue Surge Amid Hydros Launch and Saline Supply Challenges
March 04, 2025

Browse all companies